Erythema nodosum (EN) is aninflammatory condition characterized byinflammation of subcutaneous fat tissue, resulting in painful red/blue lumps or nodules that are usually seen symmetrically on both shins, on the thighs, arms, and elsewhere.[1] It can be caused by a variety of conditions but 20 to 50% of cases areidiopathic. It typically resolves spontaneously within 30 days.[2] It is common in young people aged 12–20 years.
The first signs of erythema nodosum are often flu-like symptoms such as a fever, cough,malaise, and aching joints. Some people also experience stiffness or swelling in the joints and weight loss.[3]
Erythema nodosum is characterised by 1–2-inch (25–51 mm)nodules (rounded lumps) below the skin surface, usually on the shins. Thesesubcutaneous nodules can appear anywhere on the body, but the most common sites are the shins, arms, thighs, and torso. Each nodule typically disappears after around two weeks, though new ones may continue to form for up to six or eight weeks.[3] A new nodule usually appears red and is hot and firm to the touch. The redness starts to fade and it gradually becomes softer and smaller until it disappears. Each nodule usually heals completely without scarring over the course of about two weeks.[3][4] Joint pain and inflammation sometimes continue for several weeks or months after the nodules appear.[5]
Erythema contusiforme, when a subcutaneoushemorrhage (bleeding under the skin) occurs with an erythema nodosum lesion, causing the lesion to look like acontusion (bruise)
Erythema nodosum migrans (also known assubacute nodular migratory panniculitis), a rare form of chronic erythema nodosum characterized by asymmetrical nodules that are mildly tender and migrate over time.[6][7][8]
Erythema nodosum lesion in a person with light skin and tuberculosis
A single lesion of erythema nodosum
Several lesions of erythema nodosum in an individual with dark skin
Erythema nodosum is probably a delayed hypersensitivity reaction to a variety of antigens. Although circulating immune complexes have been demonstrated in patients with inflammatory bowel disease, they have not been found in idiopathic or uncomplicated cases.[21]
Erythema nodosum is diagnosed clinically. Abiopsy can be taken and examined microscopically to confirm an uncertain diagnosis.[4] Microscopic examination usually reveals a neutrophilic infiltrate surrounding capillaries that results in septal thickening, with fibrotic changes in the fat around blood vessels. A characteristic microscopic finding is radial granulomas, well-defined nodular aggregates of histiocytes surrounding a stellate cleft.[5]
The ESR is initially very high and falls as the nodules of erythema nodosum. The ASO titer is high in cases associated with a streptococcal throat infection. Achest X-ray should be performed to rule outpulmonary diseases, in particularsarcoidosis andLöfgren syndrome.[4]
Erythema nodosum is self-limiting and usually resolves itself within 3–6 weeks. A recurring form does exist, and in children, it is attributed to repeated infections withstreptococcus.[18] Treatment should focus on the underlying cause. Symptoms can be treated with bed rest, leg elevation, compressive bandages, wet dressings, and nonsteroidal anti-inflammatory agents (NSAIDs).[5] NSAIDs are usually more effective at the onset of EN versus with chronic disease.[23]
Potassium iodide can be used for persistent lesions whose cause remains unknown.Corticosteroids andcolchicine can be used in severe refractory cases.[24][25]Thalidomide has been used successfully in the treatment of Erythema nodosum leprosum,[26] and it was approved by the U.S. FDA for this use in July 1998.[27] According to a 2009 meta-analysis, there is some evidence of benefit for both thalidomide andclofazimine in the treatment of erythema nodosum leprosum.[28]
The term, Subacute Migratory Panniculitis of Vilanova and Piñol, was named after the twoCatalan dermatologists who provided a brief description and explanation of the disease,Xavier Montiu Vilanova (1902–1965) and Joaquin Aguade Piñol (1918–1977), in 1954, and was named in 1956.[29][30]
^abcdeFitzpatrick, Thomas B. (2005).Fitzpatrick's color atlas and synopsis of clinical dermatology (5th ed.). New York: McGraw-Hill. p. 148.ISBN978-0-07-144019-6.
^Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007).Dermatology: 2-Volume Set. St. Louis: Mosby.ISBN978-1-4160-2999-1.[page needed]
^abWilliam D. James; Timothy G. Berger; Dirk M. Elston (2011).Andrews' Diseases of the skin: clinical dermatology (11th ed.). [London]: Saunders/ Elsevier. p. 488.ISBN978-1-4377-0314-6.
^abMert, Ali; Ozaras, Resat; Tabak, Fehmi; Pekmezci, Salih; Demirkesen, Cuyan; Ozturk, Recep (2009). "Erythema Nodosum: An Experience of 10 Years".Scandinavian Journal of Infectious Diseases.36 (6–7):424–7.doi:10.1080/00365540410027184.PMID15307561.S2CID13123205.
^Bohn, S; Büchner, S; Itin, P (1997). "Erythema nodosum: 112 cases. Epidemiology, clinical aspects and histopathology".Schweizerische Medizinische Wochenschrift.127 (27–28):1168–76.PMID9324739.
^Schwartz, Robert A.; Nervi, Stephen J. (2007-03-01). "Erythema nodosum: a sign of systemic disease".American Family Physician.75 (5):695–700.ISSN0002-838X.PMID17375516.
^abKumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Aster, Jon C. (2009).Robbins and Coltran Pathological Basis of Disease. Saunders/Elsevier. pp. 372–3.ISBN978-1-4160-4930-2.
^Cunha, Burke A. (1999).Infectious disease pearls. Philadelphia: Hanley & Belfus. p. 105.ISBN978-1-56053-203-3.
^Nguyen, Geoffrey C.; Torres, Esther A.; Regueiro, Miguel; Bromfield, Gillian; Bitton, Alain; Stempak, Joanne; Dassopoulos, Themistocles; Schumm, Philip; Gregory, Federico J.; Griffiths, Anne M.; Hanauer, Stephen B.; Hanson, Jennifer; Harris, Mary L.; Kane, Sunanda V.; Orkwis, Heather Kiraly; Lahaie, Raymond; Oliva-Hemker, Maria; Pare, Pierre; Wild, Gary E.; Rioux, John D.; Yang, Huiying; Duerr, Richard H.; Cho, Judy H.; Steinhart, A. Hillary; Brant, Steven R.; Silverberg, Mark S. (2006). "Inflammatory Bowel Disease Characteristics Among African Americans, Hispanics, and Non-Hispanic Whites: Characterization of a Large North American Cohort".The American Journal of Gastroenterology.101 (5):1012–23.doi:10.1111/j.1572-0241.2006.00504.x.PMID16696785.S2CID7720460.
^Mascaró, J. M. (1978). "In memoriam Joaquin Piñol Aguadé, 1918--1977".Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und Verwandte Gebiete.29 (11):613–4.PMID363649.
